Enterococcal Urinary Tract Infections: A Review of the Pathogenicity, Epidemiology, and Treatment

Urinary tract infections (UTIs) are among the most common causes of infections worldwide and can be caused by numerous uropathogens. Enterococci are Gram-positive, facultative anaerobic commensal organisms of the gastrointestinal tract that are known uropathogens. Enterococcus spp. has become a leading cause of healthcare associated infections, ranging from endocarditis to UTIs. In recent years, there has been an increase in multidrug resistance due to antibiotic misuse, especially in enterococci. Additionally, infections due to enterococci pose a unique challenge due to their ability to survive in extreme environments, intrinsic antimicrobial resistance, and genomic malleability. Overall, this review aims to highlight the pathogenicity, epidemiology, and treatment recommendations (according to the most recent guidelines) of enterococci.

[1]  T. Kramer,et al.  High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[2]  Américo Freitas,et al.  Revisiting the Frequency and Antimicrobial Resistance Patterns of Bacteria Implicated in Community Urinary Tract Infections , 2022, Antibiotics.

[3]  Zhilin Zeng,et al.  Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019 , 2022, World Journal of Urology.

[4]  B. Nathanson,et al.  Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018 , 2022, Open forum infectious diseases.

[5]  T. Huang,et al.  Prostate Microbiota and Prostate Cancer: A New Trend in Treatment , 2021, Frontiers in Oncology.

[6]  R. Aziz,et al.  Phenotype–Genotype Correlations and Distribution of Key Virulence Factors in Enterococcus faecalis Isolated from Patients with Urinary Tract Infections , 2021, Infection and drug resistance.

[7]  Benjamin Plackett.  Why big pharma has abandoned antibiotics , 2020, Nature.

[8]  B. Bartolomé,et al.  Cranberry Polyphenols and Prevention against Urinary Tract Infections: Relevant Considerations , 2020, Molecules.

[9]  Gongxian Wang,et al.  Pharmacological Interventions for Bacterial Prostatitis , 2020, Frontiers in Pharmacology.

[10]  X. Giannakopoulos,et al.  Impact of enterococcal urinary tract infections in immunocompromised - neoplastic patients. , 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[11]  K. Chu,et al.  Increasing prevalence of antimicrobial resistance in urinary tract infections of neurological patients, Seoul, South Korea, 2007-2016. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[12]  R. Chou,et al.  Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. , 2019, The Journal of urology.

[13]  Mónica A. García-Solache,et al.  The Enterococcus: a Model of Adaptability to Its Environment , 2019, Clinical Microbiology Reviews.

[14]  Kelvin K L Chong,et al.  Biofilm-associated infection by enterococci , 2018, Nature Reviews Microbiology.

[15]  A. Knezevich,et al.  Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[16]  N. Toussaint,et al.  Urinary Tract Infections in the First Year Post-Kidney Transplantation: Potential Benefits of Treating Asymptomatic Bacteriuria. , 2017, Transplantation proceedings.

[17]  C. Stief,et al.  Local epidemiology and resistance profiles in acute uncomplicated cystitis (AUC) in women: a prospective cohort study in an urban urological ambulatory setting , 2017, BMC Infectious Diseases.

[18]  Rohan B. H. Williams,et al.  Enterococcus faecalis Promotes Innate Immune Suppression and Polymicrobial Catheter-Associated Urinary Tract Infection , 2017, Infection and Immunity.

[19]  Meetu Gupta,et al.  Bacterial Virulence Factors: Secreted for Survival , 2017, Indian Journal of Microbiology.

[20]  V. Lazǎr,et al.  Microbial Biofilms in Urinary Tract Infections and Prostatitis: Etiology, Pathogenicity, and Combating strategies , 2016, Pathogens.

[21]  Lisa K. McLellan,et al.  Urinary Tract Infection: Pathogenesis and Outlook. , 2016, Trends in molecular medicine.

[22]  A. Hendrich,et al.  Study of the impact of cranberry extract on the virulence factors and biofilm formation by Enterococcus faecalis strains isolated from urinary tract infections , 2016, International journal of food sciences and nutrition.

[23]  Klinik Karar,et al.  UpToDate® , 2016, The Nurse practitioner.

[24]  C. Ghasarossian,et al.  Epidemiology of urinary tract infections, bacterial species and resistances in primary care in France , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[25]  Patrick Waters,et al.  Treatment of Ampicillin-Resistant Enterococcus faecium Urinary Tract Infections. , 2015, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.

[26]  S. Hultgren,et al.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options , 2015, Nature Reviews Microbiology.

[27]  Arto S. Baghdayan,et al.  A TIR Domain Protein from E. faecalis Attenuates MyD88-Mediated Signaling and NF-κB Activation , 2014, PloS one.

[28]  C. Arias,et al.  Mechanisms of antibiotic resistance in enterococci , 2014, Expert review of anti-infective therapy.

[29]  E. Domann,et al.  The TIR Domain Containing Locus of Enterococcus faecalis Is Predominant among Urinary Tract Infection Isolates and Downregulates Host Inflammatory Response , 2014, International journal of microbiology.

[30]  L. Hancock,et al.  Enterococcal Biofilm Structure and Role in Colonization and Disease , 2014 .

[31]  S. Hultgren,et al.  Enterococcus faecalis Overcomes Foreign Body-Mediated Inflammation To Establish Urinary Tract Infections , 2012, Infection and Immunity.

[32]  J. Pogliano,et al.  Daptomycin-Mediated Reorganization of Membrane Architecture Causes Mislocalization of Essential Cell Division Proteins , 2012, Journal of bacteriology.

[33]  Cesar A. Arias,et al.  The rise of the Enterococcus: beyond vancomycin resistance , 2012, Nature Reviews Microbiology.

[34]  E. Lin,et al.  Overtreatment of enterococcal bacteriuria. , 2012, Archives of internal medicine.

[35]  Michael S Gilmore,et al.  Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. , 2010, Current opinion in microbiology.

[36]  G. Alangaden,et al.  Treatment of Resistant Enterococcal Urinary Tract Infections , 2010, Current infectious disease reports.

[37]  T. Mikalsen,et al.  Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[38]  J. Huebner,et al.  Pathogenesis and immunity in enterococcal infections. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[39]  Sanjay Saint,et al.  Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  P. Courvalin,et al.  VanA-Type Vancomycin-Resistant Staphylococcus aureus , 2009, Antimicrobial Agents and Chemotherapy.

[41]  D. Church,et al.  Community-onset Urinary Tract Infections: A Population-based Assessment , 2007, Infection.

[42]  B. Zilberstein,et al.  Bacterial translocation: Overview of mechanisms and clinical impact , 2007, Journal of gastroenterology and hepatology.

[43]  Jona Zumeris,et al.  Effective Prevention of Microbial Biofilm Formation on Medical Devices by Low-Energy Surface Acoustic Waves , 2006, Antimicrobial Agents and Chemotherapy.

[44]  M. Gilmore,et al.  The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells , 2003, Cellular microbiology.

[45]  Fred C Tenover,et al.  Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. , 2003, The New England journal of medicine.

[46]  H. Goossens,et al.  A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. , 2003, The Journal of infectious diseases.

[47]  D. Snydman,et al.  Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  C. Solano,et al.  The Enterococcal Surface Protein, Esp, Is Involved in Enterococcus faecalis Biofilm Formation , 2001, Applied and Environmental Microbiology.

[49]  J. Jirjis,et al.  Community dissemination of vancomycin-resistant Enterococcus faecium. , 2001, American journal of infection control.

[50]  Arto S. Baghdayan,et al.  Role of Enterococcus faecalisSurface Protein Esp in the Pathogenesis of Ascending Urinary Tract Infection , 2001, Infection and Immunity.

[51]  R. Wirth,et al.  Aggregation Substance Promotes Adherence, Phagocytosis, and Intracellular Survival of Enterococcus faecalis within Human Macrophages and Suppresses Respiratory Burst , 2000, Infection and Immunity.

[52]  G. Weinstock,et al.  Enterococcus faecalis Adhesin, Ace, Mediates Attachment to Extracellular Matrix Proteins Collagen Type IV and Laminin as well as Collagen Type I , 2000, Infection and Immunity.

[53]  B. Murray,et al.  Vancomycin-resistant enterococcal infections. , 2000, The New England journal of medicine.

[54]  Alice N. Neely,et al.  Survival of Enterococci and Staphylococci on Hospital Fabrics and Plastic , 2000, Journal of Clinical Microbiology.

[55]  B. Cookson,et al.  Vancomycin-resistant enterococci , 1993, The Lancet.

[56]  K. Naber,et al.  Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. , 2008, European urology.